South & Central America Heart Transplant Market Forecast to 2030

South & Central America Heart Transplant Market Forecast to 2030 – Regional Analysis – By Surgery Type (Orthotopic Heart Transplant and Heterotopic Heart Transplant), Type (Donor Live Heart and Artificial Hearts), and End User (Hospitals, Cardiac Centers, and Others)

Send Enquiry

$2,840$4,440

Description

The South & Central America heart transplant market is expected to grow from US$ 611.18 million in 2022 to US$ 1,315.97 million by 2030. It is estimated to grow at a CAGR of 10.1% from 2022 to 2030.

Use of AI in Transplantation Procedures Fuels South & Central America Heart Transplant Market

A uniquely designed system backed by artificial intelligence (AI) facilitates the detection of early signs and seriousness of the host rejection post-heart transplantation. The endomyocardial biopsy (EMB) screening signifies the standard of care for identifying allograft rejections after a heart transplant. In 2022, a new AI system was designed known as the Cardiac Rejection Assessment Neural Estimator (CRANE), which can be used in tandem with medical assessments for rapid and precise diagnosis. CRANE also helps reduce differences regarding the presence and severity of heart rejection in the host body. It is a deep learning-based AI system for the automated assessment of gigapixel whole-slide images obtained from EMBs. In 2020, the National Institute of Health granted US$ 3.2 million to studies based on the exploration of the capabilities of AI in heart transplants. With this grant, researchers from Perelman School of Medicine (the University of Pennsylvania), Case Western Reserve University, Cleveland Clinic, and Cedars-Sinai Medical Center aimed to study what causes the rejection of a new heart and how to manage it. They used AI to analyze cardiac biopsy tissue images, finding the types of immune cells that play an instrumental role in new heart rejection. Thus, the adoption of AI in heart transplantation procedures is likely to bring new trends in the market in the coming years.

South & Central America Heart Transplant Market Overview

The heart transplant market in South & Central America is sub segmented into Brazil, Argentina, and the Rest of South & Central America. Developing healthcare facilities, increasing incidence of hypertension, a rise in the geriatric population, and the surging incidence of kidney and heart diseases are the factors that are expected to fuel the heart transplant market in South & Central America. More than half of the rejections (59%) were due to the clinical conditions of the donors, including old age, comorbidities, and infections. According to the Brazilian government, from January to November 2021, more than 12,000 organ transplants were performed in Brazil. Children were also severely affected. In 2022, 583 children aged 0-17 years were operated on for organ transplantation, same as that in 2021. ~641 new children entered the waiting list, and 66 died while waiting for an organ.

South & Central America Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Heart Transplant Market Segmentation

The South & Central America heart transplant market is segmented into surgery type, type, end user, and country.

Based on surgery type, the South & Central America heart transplant market is bifurcated into orthotopic heart transplantation and heterotopic heart transplantation. The orthotopic heart transplantation segment held a larger share of the South & Central America heart transplant market in 2022.

In terms of type, the South & Central America heart transplant market is bifurcated into donor live heart and artificial heart. The donor live heart segment held a larger share of the South & Central America heart transplant market in 2022. Further, artificial heart segment is categorized into ventricular assisted device and total artificial heart.

Based on end user, the South & Central America heart transplant market is segmented into hospitals, cardiac centers, and others. The hospitals segment held the largest share of the South & Central America heart transplant market in 2022.

Based on country, the South & Central America heart transplant market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America heart transplant market in 2022.

Terumo Corp, Abbott Laboratories, SynCardia Systems LLC, LivaNova Plc, and Calon Cardio-Technology Ltd are some of the leading companies operating in the South & Central America heart transplant market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

,

Year of Publication:

At 10.1% CAGR, South & Central America Heart Transplant Market is Speculated to be Worth US$ 1,315.97 Million by 2030, says the Research Team

According to the Research Team’ research, the South & Central America heart transplant market was valued at US$ 611.18 million in 2022 and is expected to reach US$ 1,315.97 million by 2030, registering a CAGR of 10.1% from 2022 to 2030. Improving healthcare capabilities & growing patient pool in emerging nations and growing geriatric population are among the critical factors attributed to the South & Central America heart transplant market expansion.

Emerging countries such as India, China, Argentina, Brazil, the UAE, and South Africa are expected to offer significant growth opportunities for heart transplant market players mainly due to flourishing R&D landscape, rising patient population, growing CVD awareness, improving healthcare infrastructure, burgeoning disposable incomes, and relatively lenient policies compared to developed economies. Further, the number of heart failure cases has surged in the past decade in developing countries. According to the World Economic Forum, Russia, China, Brazil, India, and South Africa were among the fastest-growing economies globally as of 2017, and they collectively accounted for one-third of total global health spending. The number of surgical centers and hospitals in developing markets would continue to grow with burgeoning healthcare spending and a rising target patient population. Therefore, the development of healthcare facilities in the developing economies, along with a surge in the number of hospitals, would in turn, result in the elevated number of heart transplantation surgeries in the coming years, creating lucrative opportunities for the heart transplant market players.

On the contrary, high cost of surgeries hampers the growth of South & Central America heart transplant market.

Based on surgery type, the South & Central America heart transplant market is bifurcated into orthotopic heart transplantation and heterotopic heart transplantation. The orthotopic heart segment held 78.7% share of South & Central America heart transplant market in 2022, amassing US$ 481.04 million. It is projected to garner US$ 1,051.39 million by 2030 to expand at 10.3% CAGR during 2022-2030.

In terms of type, the South & Central America heart transplant market is bifurcated into donor live heart and artificial heart. The donor live heart segment held 71.0% share of South & Central America heart transplant market in 2022, amassing US$ 434.19 million. It is projected to garner US$ 917.66 million by 2030 to expand at 9.8% CAGR during 2022-2030. Further, artificial heart segment is categorized into ventricular assisted device and total artificial heart.

Based on end user, the South & Central America heart transplant market is segmented into hospitals, cardiac centers, and others. The hospitals segment held 58.6% share of South & Central America heart transplant market in 2022, amassing US$ 358.26 million. It is projected to garner US$ 789.01 million by 2030 to expand at 10.4% CAGR during 2022-2030.

By country, the South & Central America heart transplant market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 66.5% share of South & Central America heart transplant market in 2022. It was assessed at US$ 406.13 million in 2022 and is likely to hit US$ 891.31 million by 2030, exhibiting a CAGR of 10.3% during 2022-2030.

Key players operating in the South & Central America heart transplant market are Terumo Corp, Abbott Laboratories, SynCardia Systems LLC, LivaNova Plc, and Calon Cardio-Technology Ltd, among others.

In June 2021, Abbott Laboratories announced that it has enhanced its capacity and supply for mechanical circulatory support (MCS) devices, Medtronic HeartWare ventricular assist device (HVAD). In addition, the company announced providing support training and education programs for its HeartMate 3 heart pump.

In January 2020, Abbott Laboratories announced that the Food and Drug Administration (FDA) approved its HeartMate 3 left ventricular assist device (LVAD). LVAD is a minimally invasive surgical technique for the placement that avoids open surgery. In 2017, the FDA approved HeartMate 3 for bridge therapy for patients awaiting a heart transplant.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America heart transplant market.
o Highlights key business priorities to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in South & Central America heart transplant market , thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Heart Transplant Market – Key Industry Dynamics
4.1 Heart Transplant Market – Key Industry Dynamics
4.2 Market Drivers
4.2.1 Increasing Target Disease Incidence
4.2.2 Growing Geriatric Population
4.3 Market Restraints
4.3.1 High Cost of Surgeries
4.4 Market Opportunities
4.4.1 Improving Healthcare Capabilities and Growing Patient Pool in Emerging Nations
4.5 Future Trends
4.5.1 Use of AI in Transplantation Procedures
4.6 Impact of Drivers and Restraints:
5. Heart Transplant Market – South & Central America Market Analysis
5.1 Heart Transplant Market Revenue (US$ Million), 2020 – 2030
5.2 Heart Transplant Market Forecast and Analysis
6. South & Central America Heart Transplant Market Analysis – Surgery Type
6.1 Overview
6.2 Orthotopic Heart Transplant
6.2.1 Overview
6.2.2 Orthotopic Heart Transplant Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Heterotopic Heart Transplant
6.3.1 Overview
6.3.2 Heterotopic Heart Transplant Market, Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Heart Transplant Market Analysis – Type
7.1 Overview
7.2 Donor Live Heart
7.2.1 Overview
7.2.2 Donor Live Heart Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Artificial Hearts
7.3.1 Overview
7.3.2 Artificial Hearts Market, Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Ventricular Assisted Device
7.3.2.1.1 Ventricular Assisted Device Market, Revenue and Forecast to 2030 (US$ Million)
7.3.2.2 Total Artificial Heart
7.3.2.2.1 Total Artificial Heart Market, Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Heart Transplant Market Analysis – End User
8.1 Overview
8.2 Hospitals
8.2.1 Overview
8.2.2 Hospitals Market, Revenue and Forecast to 2030 (US$ Million)
8.3 Cardiac Centers
8.3.1 Overview
8.3.2 Cardiac Centers Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Heart Transplant Market – Country Analysis
9.1 South & Central America
9.1.1 South & Central America Heart Transplant Market Overview
9.1.2 South & Central America Heart Transplant Market Revenue and Forecasts and Analysis – By Country
9.1.2.1 Brazil: Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.1.1 Overview
9.1.2.1.2 Brazil Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
9.1.2.1.3 Brazil Heart Transplant Market Breakdown by Surgery Type
9.1.2.1.4 Brazil Heart Transplant Market Breakdown by Type
9.1.2.1.4.1 Brazil Heart Transplant Market Breakdown by Artificial Hearts
9.1.2.1.5 Brazil Heart Transplant Market Breakdown by End User
9.1.2.2 Argentina: Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.2.1 Overview
9.1.2.2.2 Argentina Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
9.1.2.2.3 Argentina Heart Transplant Market Breakdown by Surgery Type
9.1.2.2.4 Argentina Heart Transplant Market Breakdown by Type
9.1.2.2.4.1 Argentina Heart Transplant Market Breakdown by Artificial Hearts
9.1.2.2.5 Argentina Heart Transplant Market Breakdown by End User
9.1.2.3 Rest of South & Central America: Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)
9.1.2.3.1 Overview
9.1.2.3.2 Rest of South & Central America Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
9.1.2.3.3 Rest of South & Central America Heart Transplant Market Breakdown by Surgery Type
9.1.2.3.4 Rest of South & Central America Heart Transplant Market Breakdown by Type
9.1.2.3.4.1 Rest of South & Central America Heart Transplant Market Breakdown by Artificial Hearts
9.1.2.3.5 Rest of South & Central America Heart Transplant Market Breakdown by End User
10. Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Heart Transplant Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Terumo Corp
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Abbott Laboratories
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 SynCardia Systems LLC
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 LivaNova Plc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
12. Appendix
12.1 About the Research Team

LIST OF TABLES

Table 1. Heart Transplant Market Segmentation
Table 2. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million)
Table 3. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million) – Surgery Type
Table 4. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million) – Type
Table 5. Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million) – End User
Table 6. South & Central America: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Country
Table 7. Brazil: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Surgery Type
Table 8. Brazil: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Type
Table 9. Brazil: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Artificial Hearts
Table 10. Brazil: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 11. Argentina: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Surgery Type
Table 12. Argentina: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Type
Table 13. Argentina: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Artificial Hearts
Table 14. Argentina: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 15. Rest of South & Central America: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Surgery Type
Table 16. Rest of South & Central America: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Type
Table 17. Rest of South & Central America: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By Artificial Hearts
Table 18. Rest of South & Central America: Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 19. Recent Inorganic Growth Strategies in the Heart Transplant Market
Table 20. Recent Organic Growth Strategies in the Heart Transplant Market
 

LIST OF FIGURES

Figure 1. Heart Transplant Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Heart Transplant Market Revenue (US$ Million), 2020 – 2030
Figure 4. Heart Transplant Market Share (%) – Surgery Type, 2022 and 2030
Figure 5. Orthotopic Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Heterotopic Heart Transplant Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Heart Transplant Market Share (%) – Type, 2022 and 2030
Figure 8. Donor Live Heart Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Artificial Hearts Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Ventricular Assisted Device Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Total Artificial Heart Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Heart Transplant Market Share (%) – End User, 2022 and 2030
Figure 13. Hospitals Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Cardiac Centers Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. South & Central America: Heart Transplant Market, by Key Country – Revenue (2022) (US$ Million)
Figure 17. South & Central America Heart Transplant Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 18. Brazil Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 19. Argentina Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 20. Rest of South & Central America Heart Transplant Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 21. Growth Strategies in the Heart Transplant Market

1. Terumo Corp
2. Abbott Laboratories
3. SynCardia Systems LLC
4. LivaNova Plc

Reviews

There are no reviews yet.

Be the first to review “South & Central America Heart Transplant Market Forecast to 2030”